Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00901680 · ClinicalTrials.gov registry record
Creation of the BioBank, Early Detection and Discovery Biomarkers
A clinical trial of Breast Cancer and Pancreatic Cancer, sponsored by Corewell Health East.
- Completed
- Registry status
- 3,028
- Enrollment target
- 1
- Study location
NCT00901680 is a study of Breast Cancer and Pancreatic Cancer that has completed, run by Corewell Health East. The registered enrollment target is 3,028 participants, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00901680, a study of Breast Cancer and Pancreatic Cancer, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- 3,028 participants
- Enrollment target
- 1
- Study location
Study Summary
To establish a multidisciplinary research structure for tissue repository that facilitates projects that bridge specialties that normally may or may not interact.
Conditions Studied
Study Locations (1)
Michigan
- William Beaumont Hospitals - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,028 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00901680
The ClinicalTrials.gov registry entry for NCT00901680 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,028 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00901680 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00901680 about?
NCT00901680 is a clinical study titled "Creation of the BioBank, Early Detection and Discovery Biomarkers". To establish a multidisciplinary research structure for tissue repository that facilitates projects that bridge specialties that normally may or may not interact.
What is the current status of trial NCT00901680?
This trial is currently completed. The enrollment target is 3,028 participants. The study started on 2008-08. Estimated completion is 2012-01.
What conditions does trial NCT00901680 study?
This clinical trial studies the following conditions: Breast Cancer, Pancreatic Cancer, Head and Neck Cancer.
Who is sponsoring clinical trial NCT00901680?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00901680 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.